PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 68 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $164,000 | -45.2% | 388,700 | +52.4% | 0.00% | – |
| Q4 2015 | $299,000 | +14.6% | 255,100 | 0.0% | 0.00% | – |
| Q3 2015 | $261,000 | -22.1% | 255,100 | 0.0% | 0.00% | – |
| Q2 2015 | $335,000 | -2.9% | 255,100 | 0.0% | 0.00% | – |
| Q1 2015 | $345,000 | -2.8% | 255,100 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $355,000 | +2.3% | 255,100 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $347,000 | -27.7% | 255,100 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $480,000 | -1.0% | 255,100 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $485,000 | +78.3% | 255,100 | +30.5% | 0.00% | 0.0% |
| Q4 2013 | $272,000 | -0.7% | 195,500 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $274,000 | -25.7% | 195,500 | -28.9% | 0.00% | 0.0% |
| Q2 2013 | $369,000 | – | 274,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |